Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Eclinicalmedicine
|
April 24, 2026
Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 study
FangJie Liu, DaQuan Wang, GuangYu Luo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2023
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)
Rui Zhou, Bo Qiu, Mai Xiong, et al.
Journal of Advanced Research
|
November 16, 2025
SIRT3-activating, biodegradable poly-honokiol with high drug loading for thoracic aortic dissection therapy
Xi'nan Qiao, Daquan Wang, Hanzhao Zhu, et al.
Cancer
|
December 15, 2025
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 study
PengXin Zhang, DaQuan Wang, ShaoHan Yin, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2024
Correlation of K<sup>trans</sup> derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy
DaQuan Wang, SongRan Liu, Jia Fu, et al.
Frontiers in Cellular and Infection Microbiology
|
June 20, 2022
Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy
Yu Xi, FangJie Liu, Bo Qiu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2021
Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial
Bo Qiu, DaQuan Wang, QiWen Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 12, 2022
Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [<sup>18</sup>F]FDG PET/CT imaging: quantitative analysis of [<sup>18</sup>F]FDG uptake in primary tumors and metastatic lymph nodes
DaQuan Wang, Xu Zhang, Hui Liu, et al.
Cancer Communications (London, England)
|
November 14, 2025
Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non-small cell lung cancer: a prospective phase II study (GASTO-1053)
Rui Zhou, Shiyang Zheng, Daquan Wang, et al.
Cancer Medicine
|
June 16, 2023
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)
XinLei Ai, PengXin Zhang, XinMin Xie, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Eclinicalmedicine
|
April 24, 2026
Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 study
FangJie Liu, DaQuan Wang, GuangYu Luo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2023
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)
Rui Zhou, Bo Qiu, Mai Xiong, et al.
Journal of Advanced Research
|
November 16, 2025
SIRT3-activating, biodegradable poly-honokiol with high drug loading for thoracic aortic dissection therapy
Xi'nan Qiao, Daquan Wang, Hanzhao Zhu, et al.
Cancer
|
December 15, 2025
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 study
PengXin Zhang, DaQuan Wang, ShaoHan Yin, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2024
Correlation of K<sup>trans</sup> derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy
DaQuan Wang, SongRan Liu, Jia Fu, et al.
Frontiers in Cellular and Infection Microbiology
|
June 20, 2022
Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy
Yu Xi, FangJie Liu, Bo Qiu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2021
Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial
Bo Qiu, DaQuan Wang, QiWen Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 12, 2022
Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [<sup>18</sup>F]FDG PET/CT imaging: quantitative analysis of [<sup>18</sup>F]FDG uptake in primary tumors and metastatic lymph nodes
DaQuan Wang, Xu Zhang, Hui Liu, et al.
Cancer Communications (London, England)
|
November 14, 2025
Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non-small cell lung cancer: a prospective phase II study (GASTO-1053)
Rui Zhou, Shiyang Zheng, Daquan Wang, et al.
Cancer Medicine
|
June 16, 2023
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)
XinLei Ai, PengXin Zhang, XinMin Xie, et al.
Page
of 9